Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis.
- Resource Type
- Article
- Source
- Microbiome; 6/16/2022, Vol. 10 Issue 1, p1-19, 19p
- Subject
ANTIBIOTICS DOCETAXEL PROSTATE cancer CANCER invasiveness DYSBIOSIS FECAL microbiota transplantation PROSTATE cancer patients - Language
- ISSN
- 20492618